Mutations in signaling pathways can lead to constitutive activation or inactivation of critical cellular processes. For example, hyperactivation of the PI3K/AKT/mTOR pathway promotes cancer cell survival by inhibiting apoptosis and enhancing anabolic processes. Similarly, mutations in the MAPK/ERK pathway result in sustained proliferative signaling, pushing cells towards uncontrolled growth.
